FR2407476A1 - Procede de dosage de ferritine - Google Patents

Procede de dosage de ferritine

Info

Publication number
FR2407476A1
FR2407476A1 FR7829972A FR7829972A FR2407476A1 FR 2407476 A1 FR2407476 A1 FR 2407476A1 FR 7829972 A FR7829972 A FR 7829972A FR 7829972 A FR7829972 A FR 7829972A FR 2407476 A1 FR2407476 A1 FR 2407476A1
Authority
FR
France
Prior art keywords
isoferritin
antibody
specific
ferritine
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7829972A
Other languages
English (en)
Other versions
FR2407476B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2407476A1 publication Critical patent/FR2407476A1/fr
Application granted granted Critical
Publication of FR2407476B1 publication Critical patent/FR2407476B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/801—Electron dense compounds, e.g. ferritin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LE PROCEDE SELON L'INVENTION DE DOSAGE DE FERRITINE DANS LE SERUM OU LE PLASMA CONSISTE A INCUBER UN ANTICORPS DIRIGE CONTRE UNE ISOFERRITINE SPECIFIQUE D'UN ORGANE, FIXE DE FACON COVALENTE SUR UN POLYAMIDE 6.6, D'UNE PART AVEC DES SOLUTIONS TEMOINS DE FERRITINE QUI CONTIENNENT UNE ISOFERRITINE IDENTIQUE A, OU DIFFERENTE DE CELLE UTILISEE POUR LA PRODUCTION DE L'ANTICORPS, ET D'AUTRE PART AVEC DES ECHANTILLONS DE SERUM A ANALYSER, PUIS A DECANTER LES SOLUTIONS, A LAVER LE COMPLEXE POLYAMIDE 6.6 - ISOFERRITINE - ANTICORPS SPECIFIQUE - FERRITINE AINSI FORME, PUIS A INCUBER DE NOUVEAU AVEC UN ANTICORPS ANTI-ISOFERRITINE SPECIFIQUE D'UN AUTRE ORGANE, MARQUE A I, A LAVER LE NOUVEAU COMPLEXE FORME DANS LEQUEL LES DEUX ANTICORPS SONT SPECIFIQUEMENT DIRIGES CONTRE DES ISOFERRITINES DE DIFFERENTS ORGANES, A MESURER LA RADIOACTIVITE DE CE COMPLEXE ET A COMPARER LES ECHANTILLONS TEMOINS AVEC LES ECHANTILLONS DE SERUM A ANALYSER.
FR7829972A 1977-10-29 1978-10-20 Procede de dosage de ferritine Granted FR2407476A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2748657A DE2748657C3 (de) 1977-10-29 1977-10-29 Verfahren zur Bestimmung von Ferritin

Publications (2)

Publication Number Publication Date
FR2407476A1 true FR2407476A1 (fr) 1979-05-25
FR2407476B1 FR2407476B1 (fr) 1983-06-10

Family

ID=6022625

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7829972A Granted FR2407476A1 (fr) 1977-10-29 1978-10-20 Procede de dosage de ferritine

Country Status (9)

Country Link
US (1) US4278652A (fr)
AT (1) AT364982B (fr)
BE (1) BE871648A (fr)
DE (1) DE2748657C3 (fr)
FR (1) FR2407476A1 (fr)
GB (1) GB2007363B (fr)
IT (1) IT1099550B (fr)
NL (1) NL7810755A (fr)
SE (1) SE7811204L (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62879A (en) * 1981-05-15 1985-09-29 Chaya Moroz Monoclonal antibodies,clones producing them,preparation of such antibodies and clones and cytotoxic and immunoassay using such antibodies
US5120640A (en) * 1981-05-15 1992-06-09 Chaya Moroz Placental isoferritins for the prognosis and diagnosis of immunosuppression
US4522922A (en) * 1982-04-16 1985-06-11 Jose Carro Soluble assay
US4592894A (en) * 1983-11-22 1986-06-03 The United States Of America As Represented By The United States Department Of Energy Field emission chemical sensor for receptor/binder, such as antigen/antibody
AU3440989A (en) * 1988-03-07 1989-10-05 S. Leslie Misrock Placental isoferritins for the prognosis and diagnosis of immunosuppression
CA1339958C (fr) * 1988-04-08 1998-07-21 Chaya Moroz Isoferritine, marqueur pour grossesse pathologique
CA2196559A1 (fr) * 1994-08-01 1996-02-15 Victor D. Herbert Procede pour mesurer la teneur en fer du tissu cellulaire
US5679532A (en) * 1995-12-13 1997-10-21 University Technology Corporation Serum ferritin as a predictor of the acute respiratory distress syndrome
JP7438910B2 (ja) * 2020-09-25 2024-02-27 デンカ株式会社 フェリチン測定試薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2955074A (en) * 1953-04-13 1960-10-04 Cutter Lab Heat sterilization of iron-binding globulin and adding radioactive iron thereto
US3372992A (en) * 1964-09-30 1968-03-12 Abbott Lab Method for determining blood serum iron-binding capacity
US3712291A (en) * 1968-10-02 1973-01-23 M Freeman Method for administering iron and other metals
US3925020A (en) * 1973-03-05 1975-12-09 Mallinckrodt Inc Method for determining the total iron-binding capacity of blood serum

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXBK/72 *
EXBK/74 *

Also Published As

Publication number Publication date
SE7811204L (sv) 1979-04-30
IT1099550B (it) 1985-09-18
DE2748657C3 (de) 1980-08-07
US4278652A (en) 1981-07-14
IT7829197A0 (it) 1978-10-27
AT364982B (de) 1981-11-25
ATA770278A (de) 1981-04-15
BE871648A (fr) 1979-04-30
FR2407476B1 (fr) 1983-06-10
GB2007363A (en) 1979-05-16
GB2007363B (en) 1982-08-18
NL7810755A (nl) 1979-05-02
DE2748657A1 (de) 1979-05-03
DE2748657B2 (de) 1979-10-11

Similar Documents

Publication Publication Date Title
DE3705686C2 (de) Verfahren zur Bestimmung von Antikörpern
FR2407476A1 (fr) Procede de dosage de ferritine
Sánchez et al. Janus Au-mesoporous silica nanoparticles as electrochemical biorecognition-signaling system
DE69229551D1 (de) Reagenzien, die einen nichtspezifischen bindungshemmer in einem ioneneinfang-assay enthalten
GB9902659D0 (en) Assay with reduced background
NL188544B (nl) Reagens voor immunochemische analysemethoden, uitgevoerd in aanwezigheid van een waterige vloeistof.
FR2447966A1 (fr) Conjugues analogue de ligand-inhibiteur enzymatique irreversible et procedes pour la determination des ligands les utilisant
Killard et al. Amperometric separation-free immunosensor for real-time environmental monitoring
FR2445527A1 (fr) Procede et reactifs pour la determination de l'hemoglobine glucosylee dans le sang
BE849183A (fr) Cuve a plusieurs chambres, notamment pour l'analyse automatique d'echantillons biologiques liquides
ES2112320T3 (es) Procedimientos y reactivos con captura de iones que permiten determinar el contenido en digoxina.
Stern et al. The position of the cell nucleus in pathways of hydrogen transfer: cytochrome C, flavoproteins, glutathione, and ascorbic acid
ES485763A1 (es) Un metodo directo para la determinacion de hierro en suero sanguineo
DE3854084T2 (de) Serumvorbehandlung für testverfahren zur bestimmung des vitamins b12.
FR2396976A1 (fr) Methode de dosage de cortisol sans extraction
FR2505871B1 (fr) Anticorps monoclonal, reagissant avec la ferritine oncofoetale humaine, procede de sa production et de celle du clone le donnant ainsi que les moyens pour la detection de la ferritine oncofoetale
Kim et al. Identification of retinoid-modulated proteins in squamous carcinoma cells using high-throughput immunoblotting
Koivusalo et al. Enzymic method for the quantitative determination of reduced glutathione
DE60131281T2 (de) Verfahren zum messen von gesamt-homocystein
Joh et al. A simple and sensitive assay for dopamine-β-hydroxylase
JPH05295000A (ja) 共有結合的交雑種抗体、その調製法およびこれを使用する均質的免疫検定法
ATE170927T1 (de) Ionenfang-analysenverfahren, die einen an carboxymethylamylose konjugierten bindungspartner verwenden
Liu et al. A smartphone-based fluorescent biosensor with metal-organic framework biocomposites and cotton swabs for the rapid determination of tetrodotoxin in seafood
JPS5292773A (en) Automatic analyzer
JPS5714748A (en) Kit for quantitative determination of valproic acid and its method for quantitative determination

Legal Events

Date Code Title Description
ST Notification of lapse